Fragment-based Drug Discovery Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: F6204658BBBEEN
Market Monitor Global

Abstracts

The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.

This report contains market size and forecasts of Fragment-based Drug Discovery in Global, including the following market information:

Global Fragment-based Drug Discovery Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Fragment-based Drug Discovery market was valued at 342.4 million in 2021 and is projected to reach US$ 522.5 million by 2028, at a CAGR of 6.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Fragment Screening Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Fragment-based Drug Discovery include Astex Pharmaceuticals, Alveus Pharmaceuticals, Beactica, Charles River Laboratories, Crown Bioscience, Emerald BioStructures, Evotec, Kinetic Discovery and Proteros Fragments, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fragment-based Drug Discovery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Fragment-based Drug Discovery Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Fragment-based Drug Discovery Market Segment Percentages, by Type, 2021 (%)

• Fragment Screening
• Fragment Optimization

Global Fragment-based Drug Discovery Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Fragment-based Drug Discovery Market Segment Percentages, by Application, 2021 (%)

• Academic and Research Institutions
• Biopharmaceutical Companies
• Contract Research Organizations (CROs)

Global Fragment-based Drug Discovery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Fragment-based Drug Discovery Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Fragment-based Drug Discovery revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Fragment-based Drug Discovery revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Astex Pharmaceuticals
• Alveus Pharmaceuticals
• Beactica
• Charles River Laboratories
• Crown Bioscience
• Emerald BioStructures
• Evotec
• Kinetic Discovery
• Proteros Fragments
• Sprint Bioscience
• Structure Based Design
• Sygnature Discovery

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Fragment-based Drug Discovery Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Fragment-based Drug Discovery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FRAGMENT-BASED DRUG DISCOVERY OVERALL MARKET SIZE

2.1 Global Fragment-based Drug Discovery Market Size: 2021 VS 2028
2.2 Global Fragment-based Drug Discovery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Fragment-based Drug Discovery Players in Global Market
3.2 Top Global Fragment-based Drug Discovery Companies Ranked by Revenue
3.3 Global Fragment-based Drug Discovery Revenue by Companies
3.4 Top 3 and Top 5 Fragment-based Drug Discovery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Fragment-based Drug Discovery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fragment-based Drug Discovery Players in Global Market
  3.6.1 List of Global Tier 1 Fragment-based Drug Discovery Companies
  3.6.2 List of Global Tier 2 and Tier 3 Fragment-based Drug Discovery Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Fragment-based Drug Discovery Market Size Markets, 2021 & 2028
  4.1.2 Fragment Screening
  4.1.3 Fragment Optimization
4.2 By Type - Global Fragment-based Drug Discovery Revenue & Forecasts
  4.2.1 By Type - Global Fragment-based Drug Discovery Revenue, 2017-2022
  4.2.2 By Type - Global Fragment-based Drug Discovery Revenue, 2023-2028
  4.2.3 By Type - Global Fragment-based Drug Discovery Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Fragment-based Drug Discovery Market Size, 2021 & 2028
  5.1.2 Academic and Research Institutions
  5.1.3 Biopharmaceutical Companies
  5.1.4 Contract Research Organizations (CROs)
5.2 By Application - Global Fragment-based Drug Discovery Revenue & Forecasts
  5.2.1 By Application - Global Fragment-based Drug Discovery Revenue, 2017-2022
  5.2.2 By Application - Global Fragment-based Drug Discovery Revenue, 2023-2028
  5.2.3 By Application - Global Fragment-based Drug Discovery Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Fragment-based Drug Discovery Market Size, 2021 & 2028
6.2 By Region - Global Fragment-based Drug Discovery Revenue & Forecasts
  6.2.1 By Region - Global Fragment-based Drug Discovery Revenue, 2017-2022
  6.2.2 By Region - Global Fragment-based Drug Discovery Revenue, 2023-2028
  6.2.3 By Region - Global Fragment-based Drug Discovery Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Fragment-based Drug Discovery Revenue, 2017-2028
  6.3.2 US Fragment-based Drug Discovery Market Size, 2017-2028
  6.3.3 Canada Fragment-based Drug Discovery Market Size, 2017-2028
  6.3.4 Mexico Fragment-based Drug Discovery Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Fragment-based Drug Discovery Revenue, 2017-2028
  6.4.2 Germany Fragment-based Drug Discovery Market Size, 2017-2028
  6.4.3 France Fragment-based Drug Discovery Market Size, 2017-2028
  6.4.4 U.K. Fragment-based Drug Discovery Market Size, 2017-2028
  6.4.5 Italy Fragment-based Drug Discovery Market Size, 2017-2028
  6.4.6 Russia Fragment-based Drug Discovery Market Size, 2017-2028
  6.4.7 Nordic Countries Fragment-based Drug Discovery Market Size, 2017-2028
  6.4.8 Benelux Fragment-based Drug Discovery Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Fragment-based Drug Discovery Revenue, 2017-2028
  6.5.2 China Fragment-based Drug Discovery Market Size, 2017-2028
  6.5.3 Japan Fragment-based Drug Discovery Market Size, 2017-2028
  6.5.4 South Korea Fragment-based Drug Discovery Market Size, 2017-2028
  6.5.5 Southeast Asia Fragment-based Drug Discovery Market Size, 2017-2028
  6.5.6 India Fragment-based Drug Discovery Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Fragment-based Drug Discovery Revenue, 2017-2028
  6.6.2 Brazil Fragment-based Drug Discovery Market Size, 2017-2028
  6.6.3 Argentina Fragment-based Drug Discovery Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Fragment-based Drug Discovery Revenue, 2017-2028
  6.7.2 Turkey Fragment-based Drug Discovery Market Size, 2017-2028
  6.7.3 Israel Fragment-based Drug Discovery Market Size, 2017-2028
  6.7.4 Saudi Arabia Fragment-based Drug Discovery Market Size, 2017-2028
  6.7.5 UAE Fragment-based Drug Discovery Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Astex Pharmaceuticals
  7.1.1 Astex Pharmaceuticals Corporate Summary
  7.1.2 Astex Pharmaceuticals Business Overview
  7.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Major Product Offerings
  7.1.4 Astex Pharmaceuticals Fragment-based Drug Discovery Revenue in Global Market (2017-2022)
  7.1.5 Astex Pharmaceuticals Key News
7.2 Alveus Pharmaceuticals
  7.2.1 Alveus Pharmaceuticals Corporate Summary
  7.2.2 Alveus Pharmaceuticals Business Overview
  7.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Major Product Offerings
  7.2.4 Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue in Global Market (2017-2022)
  7.2.5 Alveus Pharmaceuticals Key News
7.3 Beactica
  7.3.1 Beactica Corporate Summary
  7.3.2 Beactica Business Overview
  7.3.3 Beactica Fragment-based Drug Discovery Major Product Offerings
  7.3.4 Beactica Fragment-based Drug Discovery Revenue in Global Market (2017-2022)
  7.3.5 Beactica Key News
7.4 Charles River Laboratories
  7.4.1 Charles River Laboratories Corporate Summary
  7.4.2 Charles River Laboratories Business Overview
  7.4.3 Charles River Laboratories Fragment-based Drug Discovery Major Product Offerings
  7.4.4 Charles River Laboratories Fragment-based Drug Discovery Revenue in Global Market (2017-2022)
  7.4.5 Charles River Laboratories Key News
7.5 Crown Bioscience
  7.5.1 Crown Bioscience Corporate Summary
  7.5.2 Crown Bioscience Business Overview
  7.5.3 Crown Bioscience Fragment-based Drug Discovery Major Product Offerings
  7.5.4 Crown Bioscience Fragment-based Drug Discovery Revenue in Global Market (2017-2022)
  7.5.5 Crown Bioscience Key News
7.6 Emerald BioStructures
  7.6.1 Emerald BioStructures Corporate Summary
  7.6.2 Emerald BioStructures Business Overview
  7.6.3 Emerald BioStructures Fragment-based Drug Discovery Major Product Offerings
  7.6.4 Emerald BioStructures Fragment-based Drug Discovery Revenue in Global Market (2017-2022)
  7.6.5 Emerald BioStructures Key News
7.7 Evotec
  7.7.1 Evotec Corporate Summary
  7.7.2 Evotec Business Overview
  7.7.3 Evotec Fragment-based Drug Discovery Major Product Offerings
  7.7.4 Evotec Fragment-based Drug Discovery Revenue in Global Market (2017-2022)
  7.7.5 Evotec Key News
7.8 Kinetic Discovery
  7.8.1 Kinetic Discovery Corporate Summary
  7.8.2 Kinetic Discovery Business Overview
  7.8.3 Kinetic Discovery Fragment-based Drug Discovery Major Product Offerings
  7.8.4 Kinetic Discovery Fragment-based Drug Discovery Revenue in Global Market (2017-2022)
  7.8.5 Kinetic Discovery Key News
7.9 Proteros Fragments
  7.9.1 Proteros Fragments Corporate Summary
  7.9.2 Proteros Fragments Business Overview
  7.9.3 Proteros Fragments Fragment-based Drug Discovery Major Product Offerings
  7.9.4 Proteros Fragments Fragment-based Drug Discovery Revenue in Global Market (2017-2022)
  7.9.5 Proteros Fragments Key News
7.10 Sprint Bioscience
  7.10.1 Sprint Bioscience Corporate Summary
  7.10.2 Sprint Bioscience Business Overview
  7.10.3 Sprint Bioscience Fragment-based Drug Discovery Major Product Offerings
  7.10.4 Sprint Bioscience Fragment-based Drug Discovery Revenue in Global Market (2017-2022)
  7.10.5 Sprint Bioscience Key News
7.11 Structure Based Design
  7.11.1 Structure Based Design Corporate Summary
  7.11.2 Structure Based Design Business Overview
  7.11.3 Structure Based Design Fragment-based Drug Discovery Major Product Offerings
  7.11.4 Structure Based Design Fragment-based Drug Discovery Revenue in Global Market (2017-2022)
  7.11.5 Structure Based Design Key News
7.12 Sygnature Discovery
  7.12.1 Sygnature Discovery Corporate Summary
  7.12.2 Sygnature Discovery Business Overview
  7.12.3 Sygnature Discovery Fragment-based Drug Discovery Major Product Offerings
  7.12.4 Sygnature Discovery Fragment-based Drug Discovery Revenue in Global Market (2017-2022)
  7.12.5 Sygnature Discovery Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Fragment-based Drug Discovery Market Opportunities & Trends in Global Market
Table 2. Fragment-based Drug Discovery Market Drivers in Global Market
Table 3. Fragment-based Drug Discovery Market Restraints in Global Market
Table 4. Key Players of Fragment-based Drug Discovery in Global Market
Table 5. Top Fragment-based Drug Discovery Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Fragment-based Drug Discovery Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Fragment-based Drug Discovery Revenue Share by Companies, 2017-2022
Table 8. Global Companies Fragment-based Drug Discovery Product Type
Table 9. List of Global Tier 1 Fragment-based Drug Discovery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fragment-based Drug Discovery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Fragment-based Drug Discovery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Fragment-based Drug Discovery Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Fragment-based Drug Discovery Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Fragment-based Drug Discovery Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Fragment-based Drug Discovery Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Fragment-based Drug Discovery Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Fragment-based Drug Discovery Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Fragment-based Drug Discovery Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Fragment-based Drug Discovery Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Fragment-based Drug Discovery Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Fragment-based Drug Discovery Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Fragment-based Drug Discovery Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Fragment-based Drug Discovery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Fragment-based Drug Discovery Revenue, (US$, Mn), 2023-2028
Table 30. Astex Pharmaceuticals Corporate Summary
Table 31. Astex Pharmaceuticals Fragment-based Drug Discovery Product Offerings
Table 32. Astex Pharmaceuticals Fragment-based Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 33. Alveus Pharmaceuticals Corporate Summary
Table 34. Alveus Pharmaceuticals Fragment-based Drug Discovery Product Offerings
Table 35. Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 36. Beactica Corporate Summary
Table 37. Beactica Fragment-based Drug Discovery Product Offerings
Table 38. Beactica Fragment-based Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 39. Charles River Laboratories Corporate Summary
Table 40. Charles River Laboratories Fragment-based Drug Discovery Product Offerings
Table 41. Charles River Laboratories Fragment-based Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 42. Crown Bioscience Corporate Summary
Table 43. Crown Bioscience Fragment-based Drug Discovery Product Offerings
Table 44. Crown Bioscience Fragment-based Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 45. Emerald BioStructures Corporate Summary
Table 46. Emerald BioStructures Fragment-based Drug Discovery Product Offerings
Table 47. Emerald BioStructures Fragment-based Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 48. Evotec Corporate Summary
Table 49. Evotec Fragment-based Drug Discovery Product Offerings
Table 50. Evotec Fragment-based Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 51. Kinetic Discovery Corporate Summary
Table 52. Kinetic Discovery Fragment-based Drug Discovery Product Offerings
Table 53. Kinetic Discovery Fragment-based Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 54. Proteros Fragments Corporate Summary
Table 55. Proteros Fragments Fragment-based Drug Discovery Product Offerings
Table 56. Proteros Fragments Fragment-based Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 57. Sprint Bioscience Corporate Summary
Table 58. Sprint Bioscience Fragment-based Drug Discovery Product Offerings
Table 59. Sprint Bioscience Fragment-based Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 60. Structure Based Design Corporate Summary
Table 61. Structure Based Design Fragment-based Drug Discovery Product Offerings
Table 62. Structure Based Design Fragment-based Drug Discovery Revenue (US$, Mn), (2017-2022)
Table 63. Sygnature Discovery Corporate Summary
Table 64. Sygnature Discovery Fragment-based Drug Discovery Product Offerings
Table 65. Sygnature Discovery Fragment-based Drug Discovery Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Fragment-based Drug Discovery Segment by Type in 2021
Figure 2. Fragment-based Drug Discovery Segment by Application in 2021
Figure 3. Global Fragment-based Drug Discovery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Fragment-based Drug Discovery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Fragment-based Drug Discovery Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Fragment-based Drug Discovery Revenue in 2021
Figure 8. By Type - Global Fragment-based Drug Discovery Revenue Market Share, 2017-2028
Figure 9. By Application - Global Fragment-based Drug Discovery Revenue Market Share, 2017-2028
Figure 10. By Region - Global Fragment-based Drug Discovery Revenue Market Share, 2017-2028
Figure 11. By Country - North America Fragment-based Drug Discovery Revenue Market Share, 2017-2028
Figure 12. US Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Fragment-based Drug Discovery Revenue Market Share, 2017-2028
Figure 16. Germany Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 17. France Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Fragment-based Drug Discovery Revenue Market Share, 2017-2028
Figure 24. China Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 28. India Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Fragment-based Drug Discovery Revenue Market Share, 2017-2028
Figure 30. Brazil Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Fragment-based Drug Discovery Revenue Market Share, 2017-2028
Figure 33. Turkey Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Fragment-based Drug Discovery Revenue, (US$, Mn), 2017-2028
Figure 37. Astex Pharmaceuticals Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Beactica Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Charles River Laboratories Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Crown Bioscience Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Emerald BioStructures Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Evotec Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Kinetic Discovery Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Proteros Fragments Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sprint Bioscience Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Structure Based Design Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sygnature Discovery Fragment-based Drug Discovery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)